Home › Trial NCT00003484
Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
- Trial IDNCT00003484
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorDarell D. Bigner, MD, PhD
- Enrollment21
- Start date1997-09
- ConditionsBrain and Central Nervous System Tumors · Neuroblastoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.